The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice
Open accessAbstract
Membrane-bound proteases have recently emerged as critical mediators of tumorigenesis, angiogenesis, and metastasis. However, the mechanisms by which they regulate these processes remain unknown. As the cell surface serine protease fibroblast activation protein (FAP) is selectively expressed on tumor-associated fibroblasts and pericytes in epithelial tumors, we set out to investigate the role of FAP in mouse models of epithelial-derived solid tumors. In this study, we demonstrate that genetic deletion and pharmacologic inhibition of FAP inhibited tumor growth in both an endogenous mouse model of lung cancer driven by the K-rasG12D mutant and a mouse model of colon cancer, in which CT26 mouse colon cancer cells were transplanted into immune competent syngeneic mice. Interestingly, growth of only the K-rasG12D-driven lung tumors was also attenuated by inhibition of the closely related protease dipeptidyl peptidase IV (DPPIV). Our results indicate that FAP depletion inhibits tumor cell proliferation indirectly, increases accumulation of collagen, decreases myofibroblast content, and decreases blood vessel density in tumors. These data provide proof of principle that targeting stromal cell-mediated modifications of the tumor microenvironment may be an effective approach to treating epithelial-derived solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Down-regulation of BRCA2 Expression by Collagen Type I Promotes Prostate Cancer Cell Proliferation
Moro, L., Arbini, A., Marra, E., & Greco, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414091200 · Cited by 31
RetractedKalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Somatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Collagen reorganization at the tumor-stromal interface facilitates local invasion
Provenzano, P. P., Eliceiri, K. W., Campbell, J. M., Inman, D. R., White, J. G., & Keely, P. J. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-38 · Cited by 1,804
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179
Endothelial-pericyte interactions in angiogenesis
Gerhardt, H., & Betsholtz, C. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0745-x · Cited by 1,057
TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT
Tlsty, T. D., & Coussens, L. M. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100224 · Cited by 987
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 983
Emerging roles of proteases in tumour suppression
López-Otín, C., & Matrisian, L. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2228 · Cited by 802
Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798
Garin-Chesa, P., Old, L. J., & Rettig, W. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7235 · Cited by 748
Villhauer, E. B., Brinkman, J. A., Naderi, G. B., Burkey, B. F., Dunning, B. E., Prasad, K., Mangold, B. L., Russell, M. E., & Hughes, T. E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030091l · Cited by 613
Park, J. E., Lenter, M. C., Zimmermann, R. N., Garin-Chesa, P., Old, L. J., & Rettig, W. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36505 · Cited by 586
Scanlan, M. J., Raj, B. K., Calvo, B., Garin-Chesa, P., Sanz-Moncasi, M. P., Healey, J. H., Old, L. J., & Rettig, W. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5657 · Cited by 574
Scott, A. M., Wiseman, G., Welt, S., Adjei, A. A., Lee, F.-T., Hopkins, W., Divgi, C. R., Hanson, L. J., Mitchell, P., Gansen, D. N., et al. (2003) · PubMed · Cited by 438
Hofheinz, R.-D., al-Batran, S.-E., Hartmann, F., Hartung, G., Jäger, D., Renner, C., Tanswell, P., Kunz, U., Amelsberg, A., Kuthan, H., et al. (2003) · Oncology Research and Treatment · doi:10.1159/000069863 · Cited by 374
Clinical Implications of Fibroblast Activation Protein in Patients with Colon Cancer
Henry, L. R., Lee, H.-O., Lee, J. S., Klein-Szanto, A., Watts, P., Ross, E. A., Chen, W.-T., & Cheng, J. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1746 · Cited by 364
Rich, L. F., & Whittaker, P. (2005) · Cited by 363
Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway
Pumiglia, K. M., & Decker, S. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.448 · Cited by 356
Levy, M. T., McCaughan, G. W., Abbott, C. A., Park, J. E., Cunningham, A. M., Müller, E., Rettig, W. J., & Gorrell, M. D. (1999) · Hepatology · doi:10.1002/hep.510290631 · Cited by 336
Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma
Armstrong, T., Packham, G., Murphy, L. B., Bateman, A. C., Conti, J. A., Fine, D. R., Johnson, C. D., Benyon, R. C., & Iredale, J. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0825 · Cited by 317
Aertgeerts, K., Levin, I., Shi, L., Snell, G. P., Jennings, A., Prasad, G. S., Zhang, Y., Kraus, M. L., Salakian, S., Sridhar, V., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500092200 · Cited by 285
Welt, S., Divgi, C. R., Scott, A. M., Garin-Chesa, P., Finn, R. D., Graham, M., Carswell, E. A., Cohen, A., Larson, S. M., & Old, L. J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.6.1193 · Cited by 266
Effective Immunoconjugate Therapy in Cancer Models Targeting a Serine Protease of Tumor Fibroblasts
Ostermann, E., Garin-Chesa, P., Heider, K. H., Kalat, M., Lamche, H., Puri, C., Kerjaschki, D., Rettig, W. J., & Adolf, G. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5211 · Cited by 246
The Determination of Collagen and Elastin
Jackson, D. S., & Cleary, E. G. (1967) · Methods of Biochemical Analysis · doi:10.1002/9780470110331.ch2 · Cited by 245
Fibroblast Activation Protein and Its Relationship to Clinical Outcome in Pancreatic Adenocarcinoma
Cohen, S. J., Alpaugh, R. K., Palazzo, I., Meropol, N. J., Rogatko, A., Xu, Z., Hoffman, J. P., Weiner, L. M., & Cheng, J. D. (2008) · Pancreas · doi:10.1097/mpa.0b013e31816618ce · Cited by 243
Cheng, J. D., Dunbrack, R. L., Valianou, M., Rogatko, A., Alpaugh, R. K., & Weiner, L. M. (2002) · PubMed · Cited by 217
Besson, A., Hwang, H. C., Cicero, S., Donovan, S. L., Gurian-West, M., Johnson, D., Clurman, B. E., Dyer, M. A., & Roberts, J. M. (2007) · Genes & Development · doi:10.1101/gad.1556607 · Cited by 208
Acharya, P. S., Zukas, A., Chandan, V., Katzenstein, A.-L. A., & Puré, E. (2006) · Human Pathology · doi:10.1016/j.humpath.2005.11.020 · Cited by 204
Self-citationAdams, S., Miller, G. T., Jesson, M. I., Watanabe, T., Jones, B., & Wallner, B. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0447 · Cited by 202
The role of CD26/dipeptidyl peptidase IV in cancer
Havre, P. (2008) · Frontiers in Bioscience · doi:10.2741/2787 · Cited by 198
Rettig, W. J., Garin‐Chesa, P., Healey, J. H., Su, S. L., Ozer, H. L., Schwab, M. G., Albino, A. P., & Old, L. J. (1993) · PubMed · Cited by 188
A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer.
Wallrapp, C., Hähnel, S., Müller-Pillasch, F., Burghardt, B., Iwamura, T., Ruthenbürger, M., Lerch, M. M., Adler, G., & Gress, T. M. (2000) · PubMed · Cited by 173
Cheng, C. L., Johnson, S. P., Keir, S. T., Quinn, J. A., Ali-Osman, F., Szabo, C., Li, H., Salzman, A. L., Dolan, M. E., Modrich, P., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0128 · Cited by 171
Requirement for Rac1 in a K-ras–Induced Lung Cancer in the Mouse
Kissil, J. L., Walmsley, M. J., Hanlon, L., Haigis, K. M., Bender Kim, C. F., Sweet-Cordero, A., Eckman, M. S., Tuveson, D. A., Capobianco, A. J., Tybulewicz, V. L. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2300 · Cited by 167
Self-citationHuber, M. A., Schubert, R. D., Peter, R. U., Kraut, N., Park, J. E., Rettig, W. J., & Garin-Chesa, P. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12035.x · Cited by 162
Piñeiro-Sánchez, M. L., Goldstein, L. A., Dodt, J., Howard, L., Yeh, Y., & Chen, W.-T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7595 · Cited by 160
The Essential Role of Fibroblasts in Esophageal Squamous Cell Carcinoma–Induced Angiogenesis
Noma, K., Smalley, K. S. M., Lioni, M., Naomoto, Y., Tanaka, N., El‐Deiry, W. S., King, A. J., Nakagawa, H., & Herlyn, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.061 · Cited by 148
Christiansen, V. J., Jackson, K. W., Lee, K. N., & McKee, P. A. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.11.006 · Cited by 137
Protease inhibitors: Role and potential therapeutic use in human cancer
DeClerck, Y. A., & Imren, S. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)00460-m · Cited by 135
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer
Grimm, J., Kirsch, D. G., Windsor, S. D., Kim, C. F. B., Santiago, P. M., Ntziachristos, V., Jacks, T., & Weissleder, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503920102 · Cited by 129
Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth
Cheng, J. D., Valianou, M., Canutescu, A. A., et al. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0269 · Cited by 129
The myofibroblast and its tumours
Eyden, B. P., Banerjee, S. S., Shenjere, P., & Fisher, C. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.061630 · Cited by 125
Brandt, I., Joossens, J., Chen, X., Maes, M., Scharpé, S., Meester, I. D., & Lambeir, A. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.009 · Cited by 124
Targeted Disruption of Mouse Fibroblast Activation Protein
Niedermeyer, J., Kriz, M., Hilberg, F., Garin‐Chesa, P., Bamberger, U., Lenter, M., Park, J., Viertel, B., Püschner, H., Mauz, M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1089-1094.2000 · Cited by 119
Fibroblast activation protein: Purification, epitope mapping and induction by growth factors
Rettig, W. J., Su, S. L., Fortunato, S. R., Scanlan, M. J., Raj, B. K. M., Garin‐Chesa, P., Healey, J. H., & Old, L. J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580314 · Cited by 118
Edosada, C. Y., Quan, C. L., Wiesmann, C., Tran, T., Sutherlin, D., Reynolds, M., Elliott, J. M., Raab, H. E., Fairbrother, W. J., & Wolf, B. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511112200 · Cited by 114
Edosada, C. Y., Quan, C. L., Tran, T., Pham, V. C., Wiesmann, C., Fairbrother, W. J., & Wolf, B. B. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.087 · Cited by 106
Aggarwal, S., Brennen, W. N., Kole, T. P., Schneider, E., Topaloglu, Ö., Yates, M. S., Cotter, R. J., & Denmeade, S. R. (2007) · Biochemistry · doi:10.1021/bi701921b · Cited by 96
Bryant, P. W., Zheng, Q., & Pumiglia, K. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01612-05 · Cited by 78
Mathew, S., Scanlan, M. J., Raj, B. K. M., Murty, V. V. V. S., Garin‐Chesa, P., Old, L. J., Rettig, W. J., & Chaganti, R. S. K. (1995) · Genomics · doi:10.1016/0888-7543(95)80157-h · Cited by 76
Fibroblast activation protein and chronic liver disease
Wang, X. M. (2007) · Frontiers in bioscience · doi:10.2741/2918 · Cited by 69
Bogenrieder, T., & Herlyn, M. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00196-2 · Cited by 54
FAP-α and uPA Show Different Expression Patterns in Premalignant and Malignant Esophageal Lesions
Goscinski, M. A., Suo, Z., Flørenes, V. A., Vlatkovic, L., Nesland, J. M., & Giercksky, K.-E. (2008) · Ultrastructural Pathology · doi:10.1080/01913120802034934 · Cited by 40
Cited by
Turning foes to friends: targeting cancer-associated fibroblasts
Chen, X., & Song, E. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0004-1 · Cited by 1,879
Hallmarks of cancer: Interactions with the tumor stroma
Pietras, K., & Östman, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.045 · Cited by 1,141
Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α
Kraman, M., Bambrough, P. J., Arnold, J. N., Roberts, E. W., Magiera, L., Jones, J. O., Gopinathan, A., Tuveson, D. A., & Fearon, D. T. (2010) · Science · doi:10.1126/science.1195300 · Cited by 1,134
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 926
Dominguez, C. X., Müller, S., Keerthivasan, S., Koeppen, H., Hung, J., Gierke, S., Breart, B., Foreman, O., Bainbridge, T. W., Castiglioni, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0644 · Cited by 857
Metadata
- Authors
- Santos, A. M., Jung, J., Aziz, N., Kissil, J. L., & Puré, E.
- Venue
- Journal of Clinical Investigation
- Published
- 2009-12-01
- Volume
- 119
- Issue
- 12
- Pages
- 3613-3625
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2039675196
- Cited by
- 428
- References
- 58
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.